<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu S</submitter><funding>Department of Education of Liaoning Province</funding><funding>Natural Science Foundation of Liaoning Province</funding><pagination>111-120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11896580</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(2)</volume><pubmed_abstract>Gastric cancer is one of the most common cancers globally and has a poor prognosis. MiR-936 has been reported to regulate cell activity and tumor progression in non-small cell lung cancer, glioma, and epithelial ovarian cancer. However, the specific role and mechanism of miR-936 in gastric cancer have not been explored. In present study, gastric cancer cells were transfected with miR-936 mimic, and cell proliferation, cell cycle distribution, cell apoptosis, migration and invasion were assessed via cell-counting kit-8, flow cytometry, wound healing, and transwell assay, respectively. Dual luciferase reporter assay was used to check miR-936 binding to its downstream target. It was shown that miR-936 was downregulated in gastric cancer tissues and cells. Erb-B2 Receptor Tyrosine Kinase 4 (ER</pubmed_abstract><journal>The Kaohsiung journal of medical sciences</journal><pubmed_title>MicroRNA-936/ERBB4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion.</pubmed_title><pmcid>PMC11896580</pmcid><funding_grant_id>2019‐ZD‐0932</funding_grant_id><funding_grant_id>2019-ZD-0932</funding_grant_id><funding_grant_id>LZ2019019</funding_grant_id><pubmed_authors>Xu XD</pubmed_authors><pubmed_authors>Bao HD</pubmed_authors><pubmed_authors>Guo SB</pubmed_authors><pubmed_authors>Yu XF</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Gong J</pubmed_authors><pubmed_authors>Gong Y</pubmed_authors><pubmed_authors>Shen H</pubmed_authors><pubmed_authors>Gao S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-936/ERBB4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion.</name><description>Gastric cancer is one of the most common cancers globally and has a poor prognosis. MiR-936 has been reported to regulate cell activity and tumor progression in non-small cell lung cancer, glioma, and epithelial ovarian cancer. However, the specific role and mechanism of miR-936 in gastric cancer have not been explored. In present study, gastric cancer cells were transfected with miR-936 mimic, and cell proliferation, cell cycle distribution, cell apoptosis, migration and invasion were assessed via cell-counting kit-8, flow cytometry, wound healing, and transwell assay, respectively. Dual luciferase reporter assay was used to check miR-936 binding to its downstream target. It was shown that miR-936 was downregulated in gastric cancer tissues and cells. Erb-B2 Receptor Tyrosine Kinase 4 (ER</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2026-05-29T03:06:47.061Z</modification><creation>2026-05-29T03:05:14.633Z</creation></dates><accession>S-EPMC11896580</accession><cross_references><pubmed>33021020</pubmed><doi>10.1002/kjm2.12304</doi></cross_references></HashMap>